1988
DOI: 10.1056/nejm198802043180502
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal Management of 746 Pregnancies at Risk for Congenital Toxoplasmosis

Abstract: When infection with Toxoplasma gondii occurs during pregnancy, there is a risk that the parasite will cause severe congenital toxoplasmosis. We developed a method of diagnosing and treating congenital toxoplasmosis in utero. Diagnosis was based on the identification of maternal acute infection, followed by culture of fetal blood and amniotic fluid, testing of fetal blood for toxoplasma-specific IgM and nonspecific measures of infection, and ultrasound examination of the fetal brain. Treatment included the admi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
108
0
8

Year Published

1989
1989
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 462 publications
(119 citation statements)
references
References 5 publications
3
108
0
8
Order By: Relevance
“…In a study of 542 pregnancies in which spiramycin was given to women who seroconverted during pregnancy (388 women given treatment and 154 without treatment) the percentage of children without prenatal infection increased from 39 to 77%, and the percentage of children with severe congenital disease or intrauterine death decreased from 11 to 3% [214]. If transmission to the foetus can be documented in utero (by polymerase chain reaction (PCR) or other techniques [33]) the administration of pyrimethamine and sulfadiazine to the mother can treat the infection in utero and further decrease the severity of symptoms in infected children [216,217].…”
Section: Congenital Toxoplasmosismentioning
confidence: 99%
“…In a study of 542 pregnancies in which spiramycin was given to women who seroconverted during pregnancy (388 women given treatment and 154 without treatment) the percentage of children without prenatal infection increased from 39 to 77%, and the percentage of children with severe congenital disease or intrauterine death decreased from 11 to 3% [214]. If transmission to the foetus can be documented in utero (by polymerase chain reaction (PCR) or other techniques [33]) the administration of pyrimethamine and sulfadiazine to the mother can treat the infection in utero and further decrease the severity of symptoms in infected children [216,217].…”
Section: Congenital Toxoplasmosismentioning
confidence: 99%
“…Placental contamination is a pre-requisite to congenital infection when there is maternal parasitaemia. The infected placenta then acts as a reservoir from which the parasite can spread to the foetus leading to multi-systemic disease (Daffos et al, 1988).…”
Section: Toxoplasma Gondii Genotypes and Pathologymentioning
confidence: 99%
“…For occurrence of congenital toxoplasmosis, the primary infection should be established during pregnancy 16 . Among women infected by T. gondii during pregnancy, 61% do not transmit the disease to the fetus, 26% of the conceptions present subclinical infection (visual/or hearing deficit, neuromotor and/or learning deficit) and in 13% there is a clinical infection (hydrocephalus or microcephaly, chorioretinitis, cerebral calcification and mental retardation) 43 .…”
Section: Introductionmentioning
confidence: 99%